Eurobio Scientific to Develop New PCR Test for Male Fertility
Eurobio Scientific announced on April 26, 2022, a partnership with Dr. Nino Guy Cassuto to develop a new polymerase chain reaction (PCR) test for the diagnosis of male fertility issues.
Paris – Eurobio Scientific, a company focused on in-vitro diagnostics, has entered into a collaboration with Dr. Nino Guy Cassuto for the development of a novel PCR test aimed at assessing male fertility. The announcement was made on April 26, 2022.
The new diagnostic test is intended to provide a more precise and potentially faster method for identifying the causes of male infertility. This development is part of Eurobio Scientific's strategy to expand its portfolio in the field of reproductive health diagnostics and improve patient outcomes.
While specific details regarding the test's technology and timeline for market release were not disclosed, the partnership aims to address a significant area of unmet medical need. Male infertility affects a considerable percentage of couples attempting to conceive, and accurate diagnostics are crucial for guiding treatment.
The company stated that this collaboration underscores its commitment to advancing diagnostic solutions. Further information on the progress and availability of the test is expected to be released in due course.